- By FYH News Team
[ad_1]
Indigenous women face higher gestational diabetes rates, highlighting the intergenerational impact of diabetes.
However, the proportion of people from many ethnic groups enrolled in diabetes clinical trials remains negligible.
The UK Prospective Diabetes Study similarly underrepresented minority groups with the highest risk of macrovascular disease: 5% of patients were Indian Asian, 8% were Afro-Caribbean, and 1% were classed as other.
These studies are applied to all people globally despite population level data demonstrating variable cardiovascular risk and mortality outcomes by race, independent of therapy.
Recent trials of SGLT-2 inhibitors and GLP-1 receptor agonists showed similar rates of enrolment of diverse racial groups.
conducted in China, demonstrated that dual antiplatelet therapy prevented recurrent stroke compared to aspirin alone; its generalisability was questioned based on the ethnicity of its patient population. The POINT trial,
conducted in centres across North America, Europe, Australia, and New Zealand, showed similar results to CHANCE. POINT was deemed relevant to a wider patient population, although is not evident why its population (75% White, 20% Black, less than 4% Asian, and
The prevalence of type 1 diabetes is also rising worldwide, highlighting the need for diabetes research that is inclusive and representative of the world. However, researchers in low-income and middle-income countries have difficulty in accessing funding for RCTs, meet significant barriers to publishing in high-quality journals, and face publication costs that are often insurmountable.
in which genetic data from members of the Havasupai Tribe of Arizona was provided for diabetes research but continued to be unethically used for a wider range of studies without informed consent from the participants. In Canada, deplorable nutrition experiments done in residential schools exposed young children to chronic malnutrition, stunting, anaemia, and the risk of developing metabolic disorders such as obesity and type 2 diabetes.
Language
- •
Availability of language resources in trial handouts
- •
Use of trained health interpreters and translators during informed consent
- •
Availability of trained translators throughout the study recruitment, enrollment, and follow-up stages
Participatory community engagement
- •
Partnership with members and leaders from underrepresented communities during the planning and protocol writing stages
- •
Consideration of research techniques such as the Delphi Method to understand barriers and consider meaningful and value-based research practices, adverse effects, and health outcomes important to research participants
Participatory recruitment and enrollment
- •
Partnerships with community members and leaders to incorporate community-based recruitment strategies
- •
Development of a collaborative protocol with community members to identify representative percentage recruitment in trials
- •
Understanding of cost and cultural barriers for improvement of participant retention
Participatory leadership
Ethical consent
Ethical review, oversight, and inclusivity
- •
Inclusion of leaders and members with diverse experiences on institutional research ethics boards (REB)
- •
Ability of REBs to acknowledge and address concerns raised by community and public on ongoing studies
- •
Development of community-based REBs with inclusion of community-appointed members
Authorship
- •
Inclusion of community members, leaders, and scientists as protocol and manuscript authors based on collaboration by use of community participatory research techniques (ie, Delphi consensus, focus groups)
Knowledge translation
- •
Development of programmes, initiatives, information sources for better understanding of research results by communities
Data ownership
- •
Consideration of community data ownership practices (eg, the Canadian Ownership, Control, Access, and Possession statement by the First Nations Information Governance Centre)
Although diabetes treatment has come a long way in 100 years, we are overdue to develop and practice a framework for research that is both meaningful and representative of all patients. Ultimately, inclusivity is a matter of choice and prioritisation. Barriers and costs are not insurmountable in research; the first step requires the philosophy that all human beings deserve to benefit from fair and equitable research that represents them. We hope that the next 100 years will allow this philosophy to be enacted into practice.
SS identifies as a physician of visible minority. LR identifies as mixed Anishinaabe descent.
We declare no competing interests.
References
- 1.
- Jiang Y
- Osgood N
- Lim HJ
- et al.
Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.
CMAJ. 2014; 186: 103-109
- 2.
- Oster RT
- King M
- Morrish DW
- et al.
Diabetes in pregnancy among First Nations women in Alberta, Canada: a retrospective analysis.
BMC Pregnancy Childbirth. 2014; 14: 136
- 3.
- Cheng YJ
- Kanaya AM
- Araneta MRG
- et al.
Prevalence of diabetes by race and ethnicity in the United States, 2011–2016.
JAMA. 2019; 322: 2389-2398
- 4.
- Diabetes Control and Complications Trial Research Group
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med. 1993; 329: 977-986
- 5.
- UK Prospective Diabetes Study (UKPDS) Group
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).
Lancet. 1998; 352: 854-865
- 6.
- Ke CH
- Morgan S
- Smolina K
- Gasevic D
- Qian H
- Khan NA
Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada.
BMJ Open. 2017; 7e013808
- 7.
- Ahmed R
- de Souza RJ
- Anand SS
Assessing non-white ethnic participation in type 2 diabetes mellitus randomized clinical trials: a meta-analysis.
medRxiv. 2022; ()
- 8.
- Wang Y
- Wang Y
- Zhao X
- et al.
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.
N Engl J Med. 2013; 369: 11-19
- 9.
- Johnston SC
- Easton JD
- Farrant M
- et al.
Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA.
N Engl J Med. 2018; 379: 215-225
- 10.
- Beran D
- Laing RO
- Kaplan W
- et al.
A perspective on global access to insulin: a descriptive study of the market, trade flows and prices.
Diabet Med. 2019; 36: 726-733
- 11.
Genetic research among the Havasupai: a cautionary tale.
Virtual Mentor. 2011; 13: 113-117
- 12.
“Hunger was never absent”: how residential school diets shaped current patterns of diabetes among Indigenous peoples in Canada.
CMAJ. 2017; 189: E1043-E1045
Article Info
Publication History
Identification
Copyright
© 2022 The Author(s). Published by Elsevier Ltd.
User License
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
ScienceDirect
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Subash Kafle
- Victor Mejia
- Victor Mejia
















